Knee osteoarthritis injection study halted early
NCT ID NCT04931667
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested an injection called lorecivivint for people with knee osteoarthritis. The goal was to see if it safely reduces pain and improves knee function over three years. The study was stopped early and included 72 adults aged 40 to 80.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS OF THE KNEE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Research Site
Tucson, Arizona, 85712, United States
-
Research Site
Winter Park, Florida, 32789, United States
-
Research Site
Oak Brook, Illinois, 60523, United States
-
Research Site
Dallas, Texas, 75231, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Ultrasound may predict which patients get poor pain relief from a common knee block
- Can a new Slow-Release ibuprofen tame knee arthritis pain for 12 hours?
- Steroid cocktail may offer better pain control after knee replacement
- Can a steroid cocktail beat the standard nerve block for knee replacement pain?
- Can a pinch of hydromorphone make knee surgery recovery less painful?
- Can the right anesthesia get knee replacement patients moving faster?